Euroapi SAS
PAR:EAPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
WEG SA
OTC:WEGZY
|
BR |
|
H
|
Hbm Holdings Ltd
HKEX:2142
|
HK |
|
B
|
Buryatzoloto PAO
MOEX:BRZL
|
RU |
|
DRB Holding Co Ltd
KRX:004840
|
KR |
|
P
|
Palantir Technologies Inc
XETRA:PTX
|
US |
|
Minor International PCL
OTC:MNILY
|
TH |
Euroapi SAS
Short-Term Debt
Euroapi SAS
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
Short-Term Debt
€45.5m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
Short-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ipsen SA
PAR:IPN
|
Short-Term Debt
€4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-10%
|
|
|
Vetoquinol SA
PAR:VETO
|
Short-Term Debt
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Virbac SA
PAR:VIRP
|
Short-Term Debt
€1.2m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-21%
|
|
|
Medincell SA
PAR:MEDCL
|
Short-Term Debt
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Short-Term Debt?
Short-Term Debt
45.5m
EUR
Based on the financial report for Dec 31, 2025, Euroapi SAS's Short-Term Debt amounts to 45.5m EUR.
What is Euroapi SAS's Short-Term Debt growth rate?
Short-Term Debt CAGR 5Y
-4%
Over the last year, the Short-Term Debt growth was -10%. The average annual Short-Term Debt growth rates for Euroapi SAS have been -23% over the past three years , -4% over the past five years .
